Literature DB >> 15699451

Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells.

Chunyu Zeng1, Zhiwei Yang, Zheng Wang, John Jones, Xiaoyan Wang, Joanna Altea, Amy J Mangrum, Ulrich Hopfer, David R Sibley, Gilbert M Eisner, Robin A Felder, Pedro A Jose.   

Abstract

Angiotensin II type 1 (AT1) receptor and D1 and D3 dopamine receptors directly interact in renal proximal tubule (RPT) cells from normotensive Wistar-Kyoto rats (WKY). There is indirect evidence for a D5 and AT1 receptor interaction in WKY and spontaneously hypertensive rats (SHR). Therefore, we sought direct evidence of an interaction between AT1 and D5 receptors in RPT cells. D5 and AT1 receptors colocalized in WKY cells. Angiotensin II decreased D5 receptors in WKY cells in a time- and concentration-dependent manner (EC50=2.7x10(-9) M; t(1/2)=4.9 hours), effects that were blocked by an AT1 receptor antagonist (losartan). In SHR, angiotensin II (10(-8) M/24 hours) also decreased D5 receptors (0.96+/-0.08 versus 0.72+/-0.08; n=12) and to the same degree as in WKY cells (1.44+/-0.07 versus 0.92+/-0.08). However, basal D5 receptors were decreased in SHR RPT cells (SHR 0.96+/-0.08; WKY 1.44+/-0.07; n=12 per strain; P<0.05) and renal brush border membranes of SHR compared with WKY (SHR 0.54+/-0.16 versus WKY 1.46+/-0.10; n=5 per strain; P<0.05). Angiotensin II decreased AT1 receptor expression in WKY (1.00+/-0.04 versus 0.72+/-0.08; n=8; P<0.05) but increased it in SHR (0.96+/-0.04 versus 1.32+/-0.08; n=8; P<0.05). AT(1) and D5 receptors also interacted in vivo; renal D5 receptor protein was higher in mice lacking the AT1A receptor (AT1A-/-; 1.61+/-0.31; n=6) than in wild-type littermates used as controls (AT1A+/+; 0.81+/-0.08; n=6; P<0.05), and renal cortical AT1 receptor protein was higher in D5 receptor null mice than in wild-type littermates (1.18+/-0.08 versus 0.84+/-0.07; n=4; P<0.05). We conclude that D5 and AT1 receptors interact with each other. Altered interactions between AT1 and dopamine receptors may play a role in the pathogenesis of hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699451     DOI: 10.1161/01.HYP.0000155212.33212.99

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  44 in total

1.  Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.

Authors:  Ken Chen; Kun Deng; Xiaoyan Wang; Zhen Wang; Shuo Zheng; Hongmei Ren; Duofen He; Yu Han; Laureano D Asico; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

Review 2.  Potential dopamine-1 receptor stimulation in hypertension management.

Authors:  Mohammad Asghar; Seyed K Tayebati; Mustafa F Lokhandwala; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

Review 3.  Dopamine, the kidney, and hypertension.

Authors:  Raymond C Harris; Ming-Zhi Zhang
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

4.  Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats.

Authors:  Jian Yang; Caiyu Chen; Hongmei Ren; Yu Han; Duofen He; Lin Zhou; Ulrich Hopfer; Pedro A Jose; Chunyu Zeng
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

Review 5.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 6.  G protein-coupled receptor kinase 4: role in blood pressure regulation.

Authors:  Chunyu Zeng; Van Anthony M Villar; Gilbert M Eisner; Scott M Williams; Robin A Felder; Pedro A Jose
Journal:  Hypertension       Date:  2008-03-17       Impact factor: 10.190

7.  Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.

Authors:  Ming-Zhi Zhang; Bing Yao; Suwan Wang; Xiaofeng Fan; Guanqing Wu; Haichun Yang; Huiyong Yin; Shilin Yang; Raymond C Harris
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

Review 8.  Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance.

Authors:  John J Gildea
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

9.  Role of GRK4 in the regulation of arterial AT1 receptor in hypertension.

Authors:  Ken Chen; Chunjiang Fu; Caiyu Chen; Li Liu; Hongmei Ren; Yu Han; Jian Yang; Duofen He; Lin Zhou; Zhiwei Yang; Lianfeng Zhang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2013-11-11       Impact factor: 10.190

10.  Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats.

Authors:  Junichi Yatabe; Hironobu Sanada; Sanae Midorikawa; Shigeatsu Hashimoto; Tsuyoshi Watanabe; Peter M Andrews; Ines Armando; Xiaoyan Wang; Robin A Felder; Pedro A Jose
Journal:  Hypertens Res       Date:  2008-07       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.